AI assistant
ANI PHARMACEUTICALS INC — Director's Dealing 2024
Jun 21, 2024
31676_dirs_2024-06-20_ce7ccbb9-1805-46b7-86b8-4aef835c8669.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2024-06-17
Reporting Person: Shanmugam Muthusamy (Director, HEAD OF R&D, COO-NOVITIUM OPS)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-17 | Common Stock | S | 7946 | $61.41 | Disposed | 724674 | Indirect |
| 2024-06-18 | Common Stock | S | 10607 | $60.76 | Disposed | 714067 | Indirect |
| 2024-06-20 | Common Stock | S | 11447 | $59.86 | Disposed | 702620 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 68652 | Direct |
| Common Stock | 5000 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2023.
F2: The shares were sold in multiple trades at prices ranging from $60.77 to $62.55. The price reported above reflects the weighted average sales price.
F3: The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
F4: The shares were sold in multiple trades at prices ranging from $60.33 to $61.82. The price reported above reflects the weighted average sales price.
F5: The shares were sold in multiple trades at prices ranging from $59.40 to $60.50. The price reported above reflects the weighted average sales price.
F6: The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.